482 related articles for article (PubMed ID: 7799496)
21. The Gothenburg Breast Screening Trial.
Bjurstam N; Björneld L; Warwick J; Sala E; Duffy SW; Nyström L; Walker N; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Salander H; Säve-Söderbergh J; Wahlin T
Cancer; 2003 May; 97(10):2387-96. PubMed ID: 12733136
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of mammographic screening of the elderly: a case-referent study in the Nijmegen program in The Netherlands.
van Dijck JA; Holland R; Verbeek AL; Hendriks JH; Mravunac M
J Natl Cancer Inst; 1994 Jun; 86(12):934-8. PubMed ID: 8196083
[TBL] [Abstract][Full Text] [Related]
23. Excess mortality from breast cancer in relation to mammography screening in northern Sweden.
Lenner P; Jonsson H
J Med Screen; 1997; 4(1):6-9. PubMed ID: 9200054
[TBL] [Abstract][Full Text] [Related]
24. Likelihood of additional work-up among women undergoing routine screening mammography: the impact of age, breast density, and hormone therapy use.
Carney PA; Kasales CJ; Tosteson AN; Weiss JE; Goodrich ME; Poplack SP; Wells WS; Titus-Ernstoff L
Prev Med; 2004 Jul; 39(1):48-55. PubMed ID: 15207985
[TBL] [Abstract][Full Text] [Related]
25. Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years.
Taylor R; Page A; Bampton D; Estoesta J; Rickard M
J Med Screen; 2004; 11(4):199-206. PubMed ID: 15563775
[TBL] [Abstract][Full Text] [Related]
26. Update of the Swedish two-county program of mammographic screening for breast cancer.
Tabàr L; Fagerberg G; Duffy SW; Day NE; Gad A; Gröntoft O
Radiol Clin North Am; 1992 Jan; 30(1):187-210. PubMed ID: 1732926
[TBL] [Abstract][Full Text] [Related]
27. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.
Andersson I; Aspegren K; Janzon L; Landberg T; Lindholm K; Linell F; Ljungberg O; Ranstam J; Sigfússon B
BMJ; 1988 Oct; 297(6654):943-8. PubMed ID: 3142562
[TBL] [Abstract][Full Text] [Related]
28. Breast-cancer screening with mammography in women aged 40-49 years. Swedish Cancer Society and the Swedish National Board of Health and Welfare.
Int J Cancer; 1996 Dec; 68(6):693-9. PubMed ID: 8980168
[TBL] [Abstract][Full Text] [Related]
29. Impact of changing from annual to biennial mammographic screening on breast cancer outcomes in women aged 50-79 in British Columbia.
Coldman AJ; Phillips N; Olivotto IA; Gordon P; Warren L; Kan L
J Med Screen; 2008; 15(4):182-7. PubMed ID: 19106258
[TBL] [Abstract][Full Text] [Related]
30. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.
de Koning HJ; Boer R; Warmerdam PG; Beemsterboer PM; van der Maas PJ
J Natl Cancer Inst; 1995 Aug; 87(16):1217-23. PubMed ID: 7563167
[TBL] [Abstract][Full Text] [Related]
31. Radiation risk and mammographic screening of women from 40 to 49 years of age: effect on breast cancer rates and years of life.
Mattsson A; Leitz W; Rutqvist LE
Br J Cancer; 2000 Jan; 82(1):220-6. PubMed ID: 10638993
[TBL] [Abstract][Full Text] [Related]
32. The Gothenburg Breast Cancer Screening Trial: preliminary results on breast cancer mortality for women aged 39-49.
Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Erikson O; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säwe-Söderberg J
J Natl Cancer Inst Monogr; 1997; (22):53-5. PubMed ID: 9709276
[TBL] [Abstract][Full Text] [Related]
33. Maximizing the benefits of screening mammography for women 40-49 years old.
Bastardis-Zakas K; Iatrakis G; Navrozoglou I; Peitsidis P; Salakos N; Malakassis P; Zervoudis S
Clin Exp Obstet Gynecol; 2010; 37(4):278-82. PubMed ID: 21355457
[TBL] [Abstract][Full Text] [Related]
34. 16-year mortality from breast cancer in the UK Trial of Early Detection of Breast Cancer.
Lancet; 1999 Jun; 353(9168):1909-14. PubMed ID: 10371568
[TBL] [Abstract][Full Text] [Related]
35. Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-year follow-up of a Swedish mammographic screening.
Chiu SY; Duffy S; Yen AM; Tabár L; Smith RA; Chen HH
Cancer Epidemiol Biomarkers Prev; 2010 May; 19(5):1219-28. PubMed ID: 20406961
[TBL] [Abstract][Full Text] [Related]
36. Predictors of non-attendance for second round mammography in an Australian mammographic screening programme.
O'Byrne AM; Kavanagh AM; Ugoni A; Diver F
J Med Screen; 2000; 7(4):190-4. PubMed ID: 11202585
[TBL] [Abstract][Full Text] [Related]
37. Mammographic surveillance of asymptomatic breast cancer relatives in general practice: rate of re-attendance and GP- and patient-related barriers.
Duijm LE; Guit GL; Zaat JO
Fam Pract; 1997 Dec; 14(6):450-4. PubMed ID: 9476075
[TBL] [Abstract][Full Text] [Related]
38. Body mass index and breast cancer survival in relation to the introduction of mammographic screening.
Olsson A; Garne JP; Tengrup I; Zackrisson S; Manjer J
Eur J Surg Oncol; 2009 Dec; 35(12):1261-7. PubMed ID: 19481409
[TBL] [Abstract][Full Text] [Related]
39. Comparison of interval breast cancer rates for two-versus single-view screening mammography: a population-based study.
Seigneurin A; Exbrayat C; Labarère J; Colonna M
Breast; 2009 Oct; 18(5):284-8. PubMed ID: 19713113
[TBL] [Abstract][Full Text] [Related]
40. Estimating the accuracy of screening mammography: a meta-analysis.
Mushlin AI; Kouides RW; Shapiro DE
Am J Prev Med; 1998 Feb; 14(2):143-53. PubMed ID: 9631167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
